{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Central Islip",
      "state": "NY",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "79729",
      "recalling_firm": "InvaGen Pharmaceuticals, Inc.",
      "address_1": "550 S Research Pl",
      "address_2": "",
      "postal_code": "11722-4415",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "distribution_pattern": "U.S.A. nationwide",
      "recall_number": "D-0698-2018",
      "product_description": "Decitabine for Injection, 50mg per vial, Rx only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc., 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise, FL 33323, NDC 69097-285-37",
      "product_quantity": "3222 vials",
      "reason_for_recall": "Failed impurities/degradation specifications: Failure to water content and impurity",
      "recall_initiation_date": "20180305",
      "center_classification_date": "20180426",
      "termination_date": "20210120",
      "report_date": "20180418",
      "code_info": "Lot #: GE70493, GE70502, GE70512, Exp 8/2019",
      "more_code_info": ""
    }
  ]
}